Clinical Trial Update: The Role of Adding Concurrent Chemotherapy to IMRT in the Treatment of Stage II Nasopharyngeal Carcinoma [Phase 2]

View source ↗

Summary

This ClinicalTrials.gov entry discusses a Phase 2 study evaluating whether adding concurrent chemotherapy to intensity-modulated radiotherapy for stage II nasop…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Snippet

Sponsor: Cancer Hospital of Guangxi Medical University | Conditions: Effects of Chemotherapy | Phase 2 | Status: UNKNOWN